Insufficient scRNA-seq data for expression of POU2AF3 at single-cell level.
Insufficient scRNA-seq data for expression of POU2AF3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 99% | 241.34 | 326 / 328 | 96% | 10.81 | 170 / 178 |
thymus | 100% | 577.74 | 651 / 653 | 87% | 9.30 | 526 / 605 |
kidney | 99% | 418.98 | 88 / 89 | 87% | 9.07 | 787 / 901 |
stomach | 100% | 339.49 | 358 / 359 | 82% | 11.00 | 235 / 286 |
prostate | 100% | 532.33 | 245 / 245 | 81% | 3.21 | 409 / 502 |
esophagus | 100% | 317.63 | 1439 / 1445 | 80% | 10.29 | 146 / 183 |
intestine | 100% | 489.54 | 965 / 966 | 79% | 9.27 | 417 / 527 |
lung | 92% | 178.13 | 532 / 578 | 80% | 11.59 | 926 / 1155 |
bladder | 100% | 557.76 | 21 / 21 | 69% | 8.32 | 350 / 504 |
uterus | 100% | 547.01 | 170 / 170 | 69% | 8.10 | 317 / 459 |
brain | 88% | 255.57 | 2336 / 2642 | 80% | 6.25 | 561 / 705 |
ovary | 100% | 600.61 | 180 / 180 | 62% | 4.13 | 267 / 430 |
breast | 94% | 252.16 | 430 / 459 | 20% | 1.33 | 228 / 1118 |
adrenal gland | 84% | 140.95 | 217 / 258 | 19% | 1.18 | 44 / 230 |
liver | 54% | 56.80 | 123 / 226 | 48% | 4.01 | 194 / 406 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.46 | 1 / 1 |
blood vessel | 96% | 198.53 | 1285 / 1335 | 0% | 0 | 0 / 0 |
adipose | 89% | 178.78 | 1069 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 73% | 5.56 | 33 / 45 |
skin | 45% | 52.71 | 811 / 1809 | 5% | 0.20 | 24 / 472 |
lymph node | 0% | 0 | 0 / 0 | 34% | 7.34 | 10 / 29 |
spleen | 31% | 24.16 | 75 / 241 | 0% | 0 | 0 / 0 |
muscle | 29% | 25.65 | 231 / 803 | 0% | 0 | 0 / 0 |
heart | 24% | 20.29 | 206 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 10% | 12.91 | 93 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0070974 | Molecular function | POU domain binding |
Gene name | POU2AF3 |
Protein name | POU class 2 homeobox associating factor 3 POU class 2 homeobox associating factor 3 (Cancer susceptibility candidate protein 13) (Colorectal cancer-associated protein 2) (Protein OCA-T2) |
Synonyms | CASC13 COLCA2 C11orf93 |
Description | FUNCTION: Transcriptional coactivator that specifically associates with POU2F3 . This complex drives the development of tuft cells, a rare a rare chemosensory cells that coordinate immune and neural functions within mucosal epithelial tissues . . |
Accessions | ENST00000638573.1 [A8K830-4] ENST00000639470.1 ENST00000528846.5 ENST00000526216.1 [A8K830-1] ENST00000610738.6 [A8K830-5] A0A0A0MTE5 A0A1W2PQW7 ENST00000398035.6 [A8K830-1] ENST00000614153.4 [A8K830-1] A8K830 |